Further evidence has emerged about the beneficial effects of vitamin D in MS.
In a small Canadian study presented to the American Academy of Neurology meeting in 2009, patients were given increasing doses of vitamin D to determine its safety at high dose. Apart from finding that high doses were safe (the higher dose group averaged 14,000IU per day through the study versus 1,000IU for the group treated with standard doses by their doctors), the researchers found that the higher dose group had 2/3 fewer relapses through the course of the study.
Further, measures of immune activity showed a shift in balance away from an inflammatory profile.
This is very reassuring news for those following the OMS Program; certainly the dose of vitamin D recommended here of 5,000IU daily is very safe.
Previous research by Vieth and others has shown that 10,000IU daily is safe, even if people get a lot of sun. This current research shows that not only are these doses safe, they are also likely to reduce the relapse rate substantially.